Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 12.64
-0.14 (-1.10%)
At close: Jan 30, 2026
SWX:SANN Market Cap
SWX:SANN has a market cap or net worth of 175.98 million as of January 30, 2026. Its market cap has increased by 6.21% in one year.
Market Cap
175.98M
Enterprise Value
198.81M
Revenue
49.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.64
Market Cap Chart
Since November 3, 2006, SWX:SANN's market cap has decreased from 357.28M to 175.98M, a decrease of -50.74%. That is a compound annual growth rate of -3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 175.98M | 4.47% |
| Dec 30, 2025 | 168.45M | 0.68% |
| Dec 30, 2024 | 167.31M | 85.24% |
| Dec 29, 2023 | 90.32M | 19.92% |
| Dec 30, 2022 | 75.32M | 34.92% |
| Dec 30, 2021 | 55.82M | 3.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 916.44M |
| Basilea Pharmaceutica AG | 663.56M |
| Newron Pharmaceuticals | 389.88M |
| BioVersys AG | 140.35M |
| Xlife Sciences AG | 127.46M |
| Molecular Partners AG | 120.61M |
| EvoNext Holdings | 6.20M |
| Addex Therapeutics | 5.83M |